AUB
REGN icon

Atlantic Union Bankshares’s Regeneron Pharmaceuticals REGN Stock Holding History

Atlantic Union Bankshares’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Sell
4,186
-448
-10% -$305K 0.04% 265
2026
Q1 		$3.58M Sell
4,634
-2,232
-33% -$1.71M 0.07% 222
2025
Q4 		$5.3M Sell
6,866
-249
-3% -$169K 0.1% 182
2025
Q3 		$4M Buy
7,115
+2,818
+66% +$1.59M 0.08% 221
2025
Q2 		$2.26M Sell
4,297
-40
-0.9% -$22.3K 0.05% 248
2025
Q1 		$2.75M Buy
4,337
+341
+9% +$235K 0.17% 125
2024
Q4 		$2.85M Buy
3,996
+1,729
+76% +$1.45M 0.17% 127
2024
Q3 		$2.38M Buy
2,267
+203
+10% +$226K 0.14% 143
2024
Q2 		$2.17M Buy
2,064
+515
+33% +$499K 0.14% 136
2024
Q1 		$1.49M Buy
1,549
+115
+8% +$109K 0.13% 149
2023
Q4 		$1.26M Buy
1,434
+328
+30% +$270K 0.12% 159
2023
Q3 		$910K Buy
1,106
+163
+17% +$128K 0.09% 172
2023
Q2 		$678K Buy
943
+677
+255% +$522K 0.07% 193
2023
Q1 		$219K Buy
+266
New +$201K 0.02% 262

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Atlantic Union Bankshares's REGN Position: Q2 2026 in Review

Atlantic Union Bankshares reduced its Regeneron Pharmaceuticals (REGN) stake by 9.7% in Q2 2026, selling an estimated $305K and leaving 4,186 shares worth $2.61M. The position accounts for 0.04% of the portfolio, ranked #265.

Atlantic Union Bankshares first reported a position in REGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.3M in Q4 2025. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Atlantic Union Bankshares held 4,186 shares of Regeneron Pharmaceuticals worth $2.61M as of Q2 2026.
  • Atlantic Union Bankshares sold 448 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $305K.
  • Regeneron Pharmaceuticals made up 0.04% of Atlantic Union Bankshares's portfolio in Q2 2026, its #265 holding.
  • Atlantic Union Bankshares first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Atlantic Union Bankshares's Regeneron Pharmaceuticals position peaked at $5.3M in Q4 2025.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.